Stock screener
Filter every US stock on the same numbers behind our pages, from P/E to insider buying. Or start from one of the ready-made ideas.
290 stocks
Prices and filings as of the close on Oct 30, 2026
| # | Company | Share price | 1D | Market cap | Debt/equity | Net debt/EBITDA | Int. coverage | Current ratio | Altman Z | F-score |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | $504.80 | −10.9% | $824B | 0.05 | −1.52 | 44.1× | 2.61 | 29.80 | 8 | |
| 2 | $406.97 | −0.96% | $365B | – | 1.61 | 5.6× | 0.78 | 3.12 | 7 | |
| 3 | $250.43 | −4.1% | $256B | 0.15 | – | −4.5× | 1.57 | 22.87 | 4 | |
| 4 | $306.08 | −7.3% | $108B | – | – | −148.8× | 0.94 | 8.37 | 6 | |
| 5 | $840.70 | −8.6% | $75.4B | 0.70 | 0.94 | 24.1× | 1.68 | 16.42 | 5 | |
| 6 | $52.15 | +1.9% | $57.4B | 0.31 | 1.36 | – | 0.72 | 1.66 | 5 | |
| 7 | $258.70 | −10.9% | $44.9B | 0.00 | – | – | 10.05 | 133.04 | 5 | |
| 8 | $274.37 | −7.4% | $42.9B | 0.00 | −0.26 | 147× | 2.08 | 17.66 | 6 | |
| 9 | $32.12 | +0.38% | $42.2B | 1.09 | 3.07 | 2.3× | 4.33 | 2.44 | – | |
| 10 | $191.31 | +0.55% | $41.0B | – | – | −27.4× | 11.38 | 12.82 | 2 | |
| 11 | $83.63 | −0.82% | $34.3B | 1.15 | 1.90 | – | 0.94 | 2.50 | 6 | |
| 12 | $54.73 | −7.4% | $32.7B | 0.00 | – | – | 5.48 | 28.58 | 6 | |
| 13 | $54.87 | −9.7% | $30.3B | – | – | −0.1× | 0.46 | 0.09 | 6 | |
| 14 | $36.91 | −1.6% | $26.7B | 0.00 | – | – | 16.72 | 41.99 | 2 | |
| 15 | $124.15 | −7.1% | $25.7B | – | – | −65.0× | 1.64 | 3.59 | 6 | |
| 16 | $73.47 | −1.8% | $24.8B | – | – | 0.9× | – | 1.70 | 5 | |
| 17 | $91.73 | −29.2% | $17.6B | 0.00 | – | – | 10.49 | 32.63 | 7 | |
| 18 | $343.12 | −1.6% | $16.4B | 5.92 | 22.35 | – | 0.78 | 0.87 | 4 | |
| 19 | $94.39 | −4.5% | $11.6B | 0.00 | – | – | 2.14 | 13.48 | 6 | |
| 20 | $21.65 | −3.0% | $11.5B | 0.00 | – | – | 2.45 | 5.83 | 4 | |
| 21 | $11.04 | −3.0% | $11.5B | 0.58 | – | −1.4× | 4.11 | 1.42 | 2 | |
| 22 | $57.50 | +1.2% | $11.2B | – | – | 1.1× | – | 1.35 | 5 | |
| 23 | $83.53 | −0.64% | $10.8B | 1.23 | −0.56 | – | 1.55 | 1.97 | 4 | |
| 24 | $77.02 | −1.2% | $10.6B | 1.39 | 43.27 | 0.3× | 1.68 | 1.00 | 6 | |
| 25 | $24.30 | −7.2% | $9.9B | 0.00 | – | – | 2.01 | 0.99 | 6 | |
| 26 | $332.29 | +2.4% | $9.8B | 0.00 | – | – | 8.32 | 43.30 | 6 | |
| 27 | $110.19 | −1.1% | $9.6B | – | – | 3.7× | – | 1.44 | 6 | |
| 28 | $56.15 | −4.8% | $9.4B | 0.00 | – | – | 3.93 | 11.79 | 8 | |
| 29 | $30.37 | −1.4% | $9.4B | 0.21 | −12.35 | 39.7× | 1.08 | 1.95 | 4 | |
| 30 | $61.18 | +5.3% | $9.4B | 1.23 | 0.98 | 3.6× | 4.27 | 5.93 | 4 | |
| 31 | $35.92 | +0.17% | $8.6B | – | – | – | – | 0.62 | 5 | |
| 32 | syreSpyre Therapeutics | $96.56 | −2.4% | $8.5B | 0.00 | – | – | 18.53 | 70.18 | 4 |
| 33 | $53.76 | −0.83% | $8.3B | – | – | – | – | 0.44 | 6 | |
| 34 | $28.52 | 0.00% | $8.3B | 0.00 | – | – | – | 4.97 | – | |
| 35 | $76.29 | −1.9% | $8.3B | 0.61 | – | – | – | 0.14 | 4 | |
| 36 | $41.00 | −1.3% | $7.9B | – | – | 2.8× | – | 1.09 | 5 | |
| 37 | $25.81 | −9.0% | $7.9B | 1.03 | 1.94 | 3.2× | 1.54 | 4.13 | 6 | |
| 38 | $23.38 | −1.7% | $7.7B | 0.84 | 2.72 | 3.6× | 2.13 | 2.40 | 8 | |
| 39 | $110.90 | −3.4% | $7.7B | 0.65 | 2.27 | 4.8× | 3.10 | 3.18 | 6 | |
| 40 | $47.81 | −3.8% | $7.6B | 0.22 | 0.20 | 13.9× | 0.91 | 2.32 | 7 | |
| 41 | $65.55 | +1.0% | $7.4B | – | – | −94.2× | 2.19 | 7.46 | – | |
| 42 | $59.40 | −10.6% | $7.3B | – | – | −12.6× | 19.35 | 1.01 | 5 | |
| 43 | $18.34 | −1.1% | $7.2B | 0.29 | 0.39 | 38.1× | 2.56 | 3.29 | 8 | |
| 44 | $24.34 | +0.12% | $6.9B | 0.00 | – | – | – | 0.21 | 4 | |
| 45 | $165.13 | −3.8% | $6.8B | 0.00 | – | 15.0× | 2.04 | 2.34 | 7 | |
| 46 | $26.10 | −2.0% | $6.8B | – | – | −8.5× | 4.38 | 7.42 | 6 | |
| 47 | $322.75 | +1.7% | $6.4B | 1.17 | 11.26 | 3.1× | 1.22 | 3.58 | 6 | |
| 48 | $96.87 | +0.23% | $6.4B | 0.00 | – | – | 38.51 | 155.03 | – | |
| 49 | $51.31 | +3.3% | $6.3B | 12.69 | 0.50 | – | 1.13 | 2.48 | 7 | |
| 50 | $16.00 | −11.7% | $6.3B | 1.55 | – | – | 1.50 | 6.05 | 2 |